On the basis of these findings, we concluded that high levels of Sp1 in malignant/stemlike GBM cells modulated the balance between prosurvival and prodeath signals, thereby protecting these cells against stress conditions and cancer therapies (Figure 8). The gene discussed is SP1; the disease is cancer.